Recent clinical trials of as-needed fixed-dose combination of inhaled corticosteroid
(ICS)/formoterol have provided new evidence that may warrant a reconsideration of current …

Asthma and allergic disease impact millions of patients and are associated with high costs.
Up to 30% of all medical care involves wasted spending. Across the spectrum of care …

Introduction Asthma is one of the most common noncommunicable diseases, raising serious
concerns about asthma-related deaths globally. Studies have reported safety concerns with …

Background The management of mild asthma has lacked an over-the-counter (OTC) option
aside from inhaled epinephrine, which is available in the United States. However, inhaled …

The Global Initiative for Asthma recommends that low-dose inhaled corticosteroid
(ICS)/formoterol be preferred to short-acting beta 2-agonists as reliever therapy in …

Rationale: Air pollution caused by wildfire smoke is linked to adverse health outcomes,
especially for people living with asthma. Objectives: To evaluate whether government …

Introduction The study aims to compare the real‐world effectiveness and economy of the
budesonide/formoterol reliever and maintenance therapy (SMART) with fixed‐dose inhaled …

Objective To highlight recommendations from the Canadian Thoracic Society (CTS) 2021
asthma guideline for adults and children aged 12 years and older and to address …

Objectif Mettre en valeur les recommandations des lignes directrices de 2021 de la Société
canadienne de thoracologie (SCT) pour les adultes et les enfants de 12 ans et plus, et …

Tema/problemstilling: I dette kvalitetsforbedringsprosjektet har vi sett på praksis for
ordinering av behovsmedikasjon til astmatikere med alder over 12 år på et fastlegekontor …